CFDE Data Portal | Search ZNHIT3

	Label	Description
	ZNHIT3 associations Collection (Entity type)	Associations for ZNHIT3_associations
	ZNHIT3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE208634 1 V 2 DOXYCYCLINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	ZNHIT3 Gene (Entity type)	ENSG00000278574 - zinc finger HIT-type containing 3 [Source:HGNC Symbol;Acc:HGNC:12309]
	ZNHIT3 Gene (Entity type)	ENSG00000273611 - zinc finger HIT-type containing 3
	GSE48812 0 V 10 SULFORAPHANE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE169152 3 V 6 IBRUTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE133683 1 V 5 DOXORUBICIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE137325 2 V 0 COPANLISIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE166536 3 V 2 DOCETAXEL MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS

ZNHIT3 associations

Associations for ZNHIT3_associations

ZNHIT3 associations.tsv

A file from IDG as part of the Harmonizome project

GSE208634 1 V 2 DOXYCYCLINE HUMAN DN

A Gene Set from LINCS

ZNHIT3

ENSG00000278574 - zinc finger HIT-type containing 3 [Source:HGNC Symbol;Acc:HGNC:12309]

ZNHIT3

ENSG00000273611 - zinc finger HIT-type containing 3

GSE48812 0 V 10 SULFORAPHANE HUMAN UP

A Gene Set from LINCS

GSE169152 3 V 6 IBRUTINIB HUMAN DN

A Gene Set from LINCS

GSE133683 1 V 5 DOXORUBICIN MOUSE UP

A Gene Set from LINCS

GSE137325 2 V 0 COPANLISIB HUMAN UP

A Gene Set from LINCS

GSE166536 3 V 2 DOCETAXEL MOUSE UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.